James Neal - Nov 21, 2023 Form 4 Insider Report for PALISADE BIO, INC. (PALI)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PALI	Restricted Stock Units	Award	$0	+5.82K		$0.00	5.82K	Nov 21, 2023	Common Stock	5.82K		Direct	F1, F2, F3, F4
transaction	PALI	Common Stock Options	Award	$0	+6.88K		$0.00	6.88K	Nov 21, 2023	Common Stock	6.88K	$0.59	Direct	F1, F2, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Represents supplemental grant issued to non-employee members of Board of Directors of Issuer, which includes 5,820 restricted stock units and 6,880 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan, as amended, and were approved by the Issuer's Compensation Committee.
F2	The grants vest fully on the one (1) year anniversary of the grant date.
F3	Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
F4	N/A.
F5	Each option represents the right to purchase one share of common stock at the exercise price.